Author

N. A. Faruqui

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

A. T. Moin· 2 shared M. A. Ullah· 2 shared Y. Araf· 2 shared B. Sarkar· 1 shared D. U. S. Chowdhury· 1 shared K. Ahsan· 1 shared K. M. K. Uddin· 1 shared M. A. Moni· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. T. Moin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Unravelling the Oncogenic Potential and Prognostic Significance of CKS1B in Human Lung Adenocarcinoma and Squamous Cell Carcinoma: A Comprehensive Computational Analysis

A. T. Moin, M. A. Ullah, N. A. Faruqui, Y. Araf, T. I. Rahaman, K. Ahsan, M. O. Faruq, R. H. Bhuiyan, M. J. Hosen

bioRxiv · Apr 28, 2023 · PreprintCancer Biology

Exploring different virulent proteins of human respiratory syncytial virus for designing a novel epitope-based polyvalent vaccine: Immunoinformatics and molecular dynamics approaches

A. T. Moin, M. A. Ullah, R. B. Patil, N. A. Faruqui, B. Sarkar, Y. Araf, S. Das, K. M. K. Uddin, M. S. Hossain, M. F. Miah, M. A. Moni, D. U. S. Chowdhury, S. Islam

This study uses immunoinformatics and molecular dynamics to design a polyvalent epitope-based vaccine against RSV-A and RSV-B, selecting conserved epitopes and validating structural stability.

bioRxiv · Feb 2, 2022 · PreprintImmunology